Literature DB >> 34304585

Degradation of Premature-miR-181b by the Translin/Trax RNase Increases Vascular Smooth Muscle Cell Stiffness.

Eric Tuday1,2, Mitsunori Nakano3, Kei Akiyoshi, Xiuping Fu4, Aparna P Shah4, Atsushi Yamaguchi5, Charles Steenbergen6, Lakshmi Santhanam3, Steven S An7,8, Dan Berkowitz9, Jay M Baraban4,10, Samarjit Das3,6.   

Abstract

[Figure: see text].

Entities:  

Keywords:  aorta; cardiovascular diseases; microRNA degradation; risk factors; vascular smooth muscle; vasopressin

Mesh：

Substances：

Year:  2021        PMID： 34304585      PMCID： PMC8363557          DOI： 10.1161/HYPERTENSIONAHA.120.16690

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


  40 in total

1.  MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function.

Authors:  Sebastian Albinsson; Yajaira Suarez; Athanasia Skoura; Stefan Offermanns; Joseph M Miano; William C Sessa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-08       Impact factor: 8.311

Review 2.  Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.

Authors:  Charalambos Vlachopoulos; Konstantinos Aznaouridis; Christodoulos Stefanadis
Journal:  J Am Coll Cardiol       Date:  2010-03-30       Impact factor: 24.094

3.  Do biophysical properties of the airway smooth muscle in culture predict airway hyperresponsiveness?

Authors:  Steven S An; Ben Fabry; Xavier Trepat; Ning Wang; Jeffrey J Fredberg
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-16       Impact factor: 6.914

4.  Expression of microRNAs is essential for arterial myogenic tone and pressure-induced activation of the PI3-kinase/Akt pathway.

Authors:  Anirban Bhattachariya; Diana Dahan; Karolina M Turczyńska; Karl Swärd; Per Hellstrand; Sebastian Albinsson
Journal:  Cardiovasc Res       Date:  2013-11-13       Impact factor: 10.787

5.  Association of Pulse Wave Velocity With Chronic Kidney Disease Progression and Mortality: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort).

Authors:  Raymond R Townsend; Amanda Hyre Anderson; Julio A Chirinos; Harold I Feldman; Juan E Grunwald; Lisa Nessel; Jason Roy; Matthew R Weir; Jackson T Wright; Nisha Bansal; Chi-Yuan Hsu
Journal:  Hypertension       Date:  2018-04-30       Impact factor: 10.190

Review 6.  MitomiRs Keep the Heart Beating.

Authors:  Samarjit Das; Hannah R Vasanthi; Ramesh Parjapath
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 7.  Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature.

Authors:  Ernesto L Schiffrin
Journal:  J Cell Mol Med       Date:  2010-03-19       Impact factor: 5.310

8.  Absolute quantification of endogenous angiotensin II levels in human plasma using ESI-LC-MS/MS.

Authors:  Anna Schulz; Joachim Jankowski; Walter Zidek; Vera Jankowski
Journal:  Clin Proteomics       Date:  2014-10-27       Impact factor: 3.988

9.  MicroRNA-153 targeting of KCNQ4 contributes to vascular dysfunction in hypertension.

Authors:  Georgina Carr; Vincenzo Barrese; Jennifer B Stott; Oleksandr V Povstyan; Thomas A Jepps; Hericka B Figueiredo; Dongling Zheng; Yalda Jamshidi; Iain A Greenwood
Journal:  Cardiovasc Res       Date:  2016-11-01       Impact factor: 10.787

10.  miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling.

Authors:  Daijiro Hori; Brittany Dunkerly-Eyring; Yohei Nomura; Debjit Biswas; Jochen Steppan; Jorge Henao-Mejia; Hideo Adachi; Lakshmi Santhanam; Dan E Berkowitz; Charles Steenbergen; Richard A Flavell; Samarjit Das
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240
View more
  1 in total

1.  Translin facilitates RNA polymerase II dissociation and suppresses genome instability during RNase H2- and Dicer-deficiency.

Authors:  Natalia Gomez-Escobar; Ahad A A Alsaiari; Hanadi A S Alahamadi; Othman Alzahrani; Ellen Vernon; Hussam A E Althagafi; Nasser S Almobadel; David W Pryce; Jane A Wakeman; Ramsay J McFarlane
Journal:  PLoS Genet       Date:  2022-06-17       Impact factor: 6.020
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.